- Case Summary:
Pfizer and those claiming injuries resulting from the company’s 1996 clinical trial in Nigeria during a meningitis epidemic reach a settlement in federal district court, ending litigation that was first filed in 2001. - Key Takeaway:
The settlement follows a separate one with Nigerian federal and state governments and uses the fund established in the Nigerian agreement.
Fifteen years after its drug trial on children with meningitis in Nigeria ended, Pfizer Inc. and all of the plaintiffs in the two remaining federal district court cases announced Feb. 22 they had reached a settlement (Abdullahi v. Pfizer Inc.; ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.